taxonomy (2)
protein (52)
source (10)
structure (1)
composition (1)
disease (13)
reference (20)
site (98)
peptide (98)
- ADAM DEC1 / Homo sapiens O15204
- Alpha-1-antichymotrypsin / Homo sapiens P01011
- Alpha-1-antitrypsin / Homo sapiens P01009
- Alpha-S1-casein / Homo sapiens P47710
- Angiotensin-converting enzyme 2 / Homo sapiens Q9BYF1
- Apolipoprotein D / Homo sapiens P05090
- Beta-2-glycoprotein 1 / Homo sapiens P02749
- Butyrophilin subfamily 1 member A1 / Homo sapiens Q13410
- Carbonic anhydrase 6 / Homo sapiens P23280
- Ceruloplasmin / Homo sapiens P00450
- Chordin-like protein 2 / Homo sapiens Q6WN34
- Clusterin / Homo sapiens P10909
- Coagulation factor XI / Homo sapiens P03951
- Complement c4-a / Homo sapiens P0C0L4
- Complement C4-B / Homo sapiens P0C0L5
- Erythropoietin / Homo sapiens P01588
- Galectin-3-binding protein / Homo sapiens Q08380
- Glucosylceramidase / Homo sapiens P04062
- Haptoglobin / Homo sapiens P00738
- Hemopexin / Homo sapiens P02790
- Immunoglobulin alpha (non secretory) / Homo sapiens P01877 P01876
- Immunoglobulin epsilon chain c region / Homo sapiens P01854
- Immunoglobulin gamma / Homo sapiens P01857 P01860 P01859 P01861
- Immunoglobulin heavy constant alpha 1 / Homo sapiens P01876
- Immunoglobulin heavy constant alpha 2 / Homo sapiens P01877
- Immunoglobulin heavy constant mu / Homo sapiens P01871
- Immunoglobulin J chain / Homo sapiens P01591
- Inter-alpha-trypsin inhibitor heavy chain h4 / Homo sapiens Q14624
- Lactadherin / Homo sapiens Q08431
- Lactotransferrin / Homo sapiens P02788
- Leucine-rich alpha-2-glycoprotein / Homo sapiens P02750
- Lipoprotein lipase / Homo sapiens P06858
- Low affinity immunoglobulin gamma Fc region receptor III-A (FcγRIIIa ) / Homo sapiens P08637
- Lumican / Homo sapiens P51884
- Macrophage mannose receptor 1 / Homo sapiens P22897
- Metalloproteinase inhibitor 1 / Homo sapiens P01033
- Platelet glycoprotein 4 / Homo sapiens P16671
- Polymeric immunoglobulin receptor / Homo sapiens P01833
- Prosaposin / Homo sapiens P07602
- Recombinant Mucin-1 Muc1f/4tr / Homo sapiens Q99102 P15941
- Selenoprotein P / Homo sapiens P49908
- Sparc-like protein 1 / Homo sapiens Q14515
- Sulfhydryl oxidase 1 / Homo sapiens O00391
- Tenascin / Homo sapiens P24821
- Thrombospondin-1 / Homo sapiens P07996
- Toll-like receptor 2 / Homo sapiens O60603
- Trans-Golgi network integral membrane protein 2 / Homo sapiens O43493
- Tumor necrosis factor ligand superfamily member 13 / Homo sapiens O75888
- Tumor necrosis factor receptor superfamily member 11B / Homo sapiens O00300
- Vitronectin / Homo sapiens P04004
- Zinc-alpha-2-glycoprotein / Homo sapiens P25311
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) P0DTC2
Protein
- Blood Plasma (UBERON_0001969)
- Blood Serum (UBERON_0001977) Mature NK T cell (CL_0000814)
- Blood Serum (UBERON_0001977)
- Colostrum (UBERON_0001914)
- Kidney (UBERON_0002113) HEK293 (CVCL_0045)
- Milk (UBERON_0001913)
- Ovary (UBERON_0000992) CHO (CVCL_0213)
- HEK293 (CVCL_0045)
- EBV-transformed B-cell (CL_0000236)
- Neutrophil (CL_0000775)
Source
- N-Linked / Complex / Structure 1519
Reported structure
- Atopic dermatitis (DOID:3310)
- Control/Healthy
- COVID-19 (DOID:0080600)
- Esophageal cancer (DOID:5041)
- Gastritis (DOID:4029)
- Hyper IgE syndrome (DOID:0080545)
- Hyper IgE syndrome (HIES, p.Glu340del) (DOID:0080545)
- Hyper IgE syndrome (PGM3 mutation, p.Asp507Tyr) (DOID:0080545)
- Hyper IgE syndrome (PGM3 mutation, p.Leu83Ser) (DOID:0080545)
- Hyperimmune condition
- IgE myeloma (DOID:9538)
- Multiple myeloma (DOID:9538)
- Systemic lupus erythematosus (DOID:9074)
Disease
- Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins using High-Resolution Mass Spectrometry (2020 - Yong Zhang, Wanjun Zhao, Yonghong Mao, Shisheng Wang, Yi Zhong, Tao Su, Meng Gong, Xiaofeng Lu, Jingqiu Cheng, Hao Yang) / Status : Reviewed
- Comprehensive characterization of N- and O- glycosylation of SARS-CoV-2 human receptor angiotensin converting enzyme 2. (2020 - Asif Shajahan, Stephanie Archer-Hartmann, Nitin T. Supekar, Anne S. Gleinich, Christian Heiss, and Parastoo Azadi) / Status : Reviewed
- Cysteine Aminoethylation Enables the Site-Specific Glycosylation Analysis of Recombinant Human Erythropoietin using Trypsin (2020 - Steffen Lippold, Alexander Büttner, Matthew S.F. Choo, Michaela Hook, Coen J. de Jong, Terry Nguyen-Khuong, Markus Haberger, Dietmar Reusch, Manfred Wuhrer, Noortje de Haan) / Status : Reviewed
- Quantitative Longitudinal Inventory of the N-Glycoproteome of Human Milk from a Single Donor Reveals the Highly Variable Repertoire and Dynamic Site-Specific Changes (2020 - Jing Zhu, Yu-Hsien Lin, Kelly A Dingess, Marko Mank, Bernd Stahl, Albert J R Heck) / Status : Reviewed
- Primary Human Natural Killer Cells Retain Proinflammatory IgG1 at the Cell Surface and Express CD16a Glycoforms with Donor-dependent Variability. (2019 - Patel KR, Nott JD, Barb AW) / Status : Unreviewed
- A Microarray-Matrix-assisted Laser Desorption/Ionization-Mass Spectrometry Approach for Site-specific Protein N-glycosylation Analysis, as Demonstrated for Human Serum Immunoglobulin M (IgM) (2015 - Martin Pabst, Simon Karl Küster, Fabian Wahl, Jasmin Krismer, Petra S.Dittrich, Renato Zenobi) / Status : Reviewed
- A Method for Comprehensive Glycosite-Mapping and Direct Quantitation of Serum Glycoproteins (2015 - Qiuting Hong, L. Renee Ruhaak, Carol Stroble, Evan Parker, Jincui Huang, Emanual Maverakis, Carlito B. Lebrilla) / Status : Reviewed
- The serum immunoglobulin G glycosylation signature of gastric cancer (2015 - L. Renee Ruhaak, Donald A. Barkauskas, Javier Torres, Cara L. Cooke, Lauren D. Wu, Carol Stroble, Sureyya Ozcan, Cynthia C. Williams, Margarita Camorlinga, David M. Rocke, Carlito B. Lebrilla, Jay V. Solnick,) / Status : Reviewed
- Expression and glycoengineering of functionally active heteromultimeric IgM in plants (2014 - Loos A, Gruber C, Altmann F, Mehofer U, Hensel F, Grandits M, Oostenbrink C, Stadlmayr G, Furtmüller PG, Steinkellner H) / Status : Reviewed
- In-depth analysis of site-specific N-glycosylation in vitronectin from human plasma by tandem mass spectrometry with immunoprecipitation (2014 - Hwang H, Lee JY, Lee HK, Park GW, Jeong HK, Moon MH, Kim JY, Yoo JS.) / Status : Reviewed
- Site-specific N-glycosylation analysis of human immunoglobulin E. (2014 - Plomp R, Hensbergen PJ, Rombouts Y, Zauner G, Dragan I, Koeleman CA, Deelder AM, Wuhrer M) / Status : Reviewed
- Site-specific glycan microheterogeneity of inter-alpha-trypsin inhibitor heavy chain H4 (2014 - Chandler KB, Brnakova Z, Sanda M, Wang S, Stalnaker SH, Bridger R, Zhao P, Wells L, Edwards NJ, Goldman R.) / Status : Reviewed
- Hypomorphic homozygous mutations in phosphoglucomutase 3 (PGM3) impair immunity and increase serum IgE levels, (2014 - Atfa Sassi, Sandra Lazaroski, Gang Wu, Stuart M. Haslam, Manfred Fliegauf, Fethi Mellouli, Turkan Patiroglu, Ekrem Unal, Mehmet Akif Ozdemir, Zineb Jouhadi, Khadija Khadir, Leila Ben-Khemis, Meriem Ben-Ali, Imen Ben-Mustapha, Lamia Borchani, Dietmar Pfeifer, Thilo Jakob, Monia Khemiri, A. Charlotta Asplund, Manuela O. Gustafsson, Karin E. Lundin, Elin Falk-Sörqvist, Lotte N. Moens, Hatice Eke Gungor, Karin R. Engelhardt, Magdalena Dziadzio, Hans Stauss, Bernhard Fleckenstein, Rebecca Meier, Khairunnadiya Prayitno, Andrea Maul-Pavicic, Sandra Schaffer, Mirzokhid Rakhmanov, Philipp Henneke, Helene Kraus, Hermann Eibel, Uwe Kölsch, Sellama Nadifi, Mats Nilsson, Mohamed Bejaoui, Alejandro A. Schäffer, C.I. Edvard Smith, Anne Dell, Mohamed-Ridha Barbouche, Bodo Grimbacher) / Status : Reviewed
- Site-specific N-glycosylation analysis of human factor XI: Identification of a noncanonical NXC glycosite (2014 - Faid V, Denguir N, Chapuis V, Bihoreau N, Chevreux G) / Status : Reviewed
- Computational framework for identification of intact glycopeptides in complex samples (2014 - Mayampurath A, Yu CY, Song E, Balan J, Mechref Y, Tang H.) / Status : Reviewed
- Loci Associated with N-Glycosylation of Human Immunoglobulin G Show Pleiotropy with Autoimmune Diseases and Haematological Cancers (2013 - Gordan Lauc, Jennifer E. Huffman, Maja Pučić, Lina Zgaga, Barbara Adamczyk, Ana Mužinić, Mislav Novokmet, Ozren Polašek, Olga Gornik, Jasminka Krištić, Toma Keser, Veronique Vitart, Blanca Scheijen, Hae-Won Uh, Mariam Molokhia, Alan Leslie Patrick, Paul McKeigue,Ivana Kolčić, Ivan Krešimir Lukić, Olivia Swann, Frank N. van Leeuwen, L. Renee Ruhaak, Jeanine J. Houwing-Duistermaat, P. Eline Slagboom, Marian Beekman, Anton J. M. de Craen, André M. Deelder, Qiang Zeng, Wei Wang, Nicholas D. Hastie, Ulf Gyllensten, James F. Wilson, Manfred Wuhrer, Alan F. Wright, Pauline M. Rudd, Caroline Hayward, Yurii Aulchenko, Harry Campbell, Igor Rudan) / Status : Reviewed
- Exploring site-specific N-glycosylation microheterogeneity of haptoglobin using glycopeptide CID tandem mass spectra and glycan database search (2013 - Chandler KB1, Pompach P, Goldman R, Edwards N.) / Status : Reviewed
- GlycoSpectrumScan: Fishing Glycopeptides from MS Spectra of Protease Digests of Human Colostrum sIgA (2010 - Nandan Deshpande, Pia H. Jensen, Nicolle H. Packer, Daniel Kolarich) / Status : Reviewed
- Differential Glycosylation of Polymeric and Monomeric IgA: A Possible Role in Glomerular Inflammation in IgA Nephropathy (2006 - Beatrijs D. Oortwijn, Anja Roos, Louise Royle, Daniëlle J. van Gijlswijk-Janssen, Maria C. Faber-Krol, Jan-Willem Eijgenraam, Raymond A. Dwek, Mohamed R. Daha, Pauline M. Rudd, Cees van Kooten) / Status : Reviewed
- Human Serum IgM Glycosylation: IDENTIFICATION OF GLYCOFORMS THAT CAN BIND TO MANNAN-BINDING LECTIN (2005 - James N.Arnold, Mark R.Wormald, David M.Suter, Catherine M.Radcliffe, David J.Harvey, Raymond A.Dwek, Pauline M.Rudd, Robert B.Sim) / Status : Reviewed
Reference
- ADAM DEC1 / Homo sapiens
- Alpha-1-antichymotrypsin / Homo sapiens
- Alpha-1-antitrypsin / Homo sapiens
- Alpha-S1-casein / Homo sapiens
-
Angiotensin-converting enzyme 2 / Homo sapiens
- Undefined site
- Apolipoprotein D / Homo sapiens
- Beta-2-glycoprotein 1 / Homo sapiens
- Butyrophilin subfamily 1 member A1 / Homo sapiens
- Carbonic anhydrase 6 / Homo sapiens
- Ceruloplasmin / Homo sapiens
- Chordin-like protein 2 / Homo sapiens
- Clusterin / Homo sapiens
- Coagulation factor XI / Homo sapiens
- Complement c4-a / Homo sapiens
- Complement C4-B / Homo sapiens
- Erythropoietin / Homo sapiens
- Galectin-3-binding protein / Homo sapiens
- Glucosylceramidase / Homo sapiens
- Haptoglobin / Homo sapiens
- Hemopexin / Homo sapiens
-
Immunoglobulin alpha (non secretory) / Homo sapiens
- Undefined site
- Immunoglobulin epsilon chain c region / Homo sapiens
-
Immunoglobulin gamma / Homo sapiens
- Undefined site
- Immunoglobulin heavy constant alpha 1 / Homo sapiens
- Immunoglobulin heavy constant alpha 2 / Homo sapiens
- Immunoglobulin heavy constant mu / Homo sapiens
- Immunoglobulin J chain / Homo sapiens
- Inter-alpha-trypsin inhibitor heavy chain h4 / Homo sapiens
- Lactadherin / Homo sapiens
- Lactotransferrin / Homo sapiens
- Leucine-rich alpha-2-glycoprotein / Homo sapiens
- Lipoprotein lipase / Homo sapiens
- Low affinity immunoglobulin gamma Fc region receptor III-A (FcγRIIIa ) / Homo sapiens
- Lumican / Homo sapiens
- Macrophage mannose receptor 1 / Homo sapiens
- Metalloproteinase inhibitor 1 / Homo sapiens
- Platelet glycoprotein 4 / Homo sapiens
- Polymeric immunoglobulin receptor / Homo sapiens
- Prosaposin / Homo sapiens
- Recombinant Mucin-1 Muc1f/4tr / Homo sapiens
- Selenoprotein P / Homo sapiens
- Sparc-like protein 1 / Homo sapiens
- Sulfhydryl oxidase 1 / Homo sapiens
- Tenascin / Homo sapiens
- Thrombospondin-1 / Homo sapiens
- Toll-like receptor 2 / Homo sapiens
- Trans-Golgi network integral membrane protein 2 / Homo sapiens
- Tumor necrosis factor ligand superfamily member 13 / Homo sapiens
- Tumor necrosis factor receptor superfamily member 11B / Homo sapiens
- Vitronectin / Homo sapiens
- Zinc-alpha-2-glycoprotein / Homo sapiens
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
Reported glycosite
- KQEEAGVRPSAGNVSTHPSLSQRPGGSTKS (30aa)
- YKNNSDISSTR (11aa)
- NNSDISSTR (9aa)
- EAENITTGC (9aa)
- KFVGTPEVNQTTLYQRY (17aa)
- RLSPNASAEHLELRW (15aa)
- FHNESLISSQASSY (14aa)
- KGLNMTGYETQAGEFPMVNNGHTVQISLPSTMRM (34aa)
- RNESTQNCVVAEPEKM (16aa)
- RALGFENATQALGRA (15aa)
- KDTRNESTQNCVVAEPEKM (19aa)
- RTPEDTAEDTCHLIPGVAESVATCHFNHSSKT (32aa)
- ENISDPTSPLR (11aa)
- IIVPLNNRENISDPTSPLR (19aa)
- RIIVPLNNRENISDPTSPLRT (21aa)
- RENISDPTSPLRT (13aa)
- RANLTNFPENGTFVVNIAQLSQDDSGRY (28aa)
- KNNATVHEQVGGPSLTSDLQAQSKG (25aa)
- KKKEDALNETRE (12aa)
- KKKEDALNETRESETKL (17aa)
- KEDALNETRESETKL (15aa)
- KKEDALNETRESETKL (16aa)
- KKEDALNETRE (11aa)
- RADGTVNQIEGEATPVNLTEPAKL (24aa)
- KTCDWLPKPNMSASCKE (17aa)
- RSHNRSEEFLIAGKL (15aa)
- KNDTLLGIKG (10aa)
- KFNLTETSEAEIHQSFQHLLRT (22aa)
- KDIVEYYNDSNGSHVLQGRF (20aa)
- KSCQHNGTMYQHGEIFSAHELFPSRL (26aa)
- KVSEHIPVYQQEENQTDVWTLLNGSKD (27aa)
- TQSLLIVNNATNVVIK (16aa)
- KQHSVLHLVPINATSKD (17aa)
- KKLHINHNNLTESVGPLPKS (20aa)
- KLHINHNNLTESVGPLPKS (19aa)
- KNGSGAVFPVAGADVQTLRE (20aa)
- RGLSFDVSLEVSQGPGLLNDTKV (23aa)
- KEHEGAIYPDNTTDFQRA (18aa)
- KEHEGAIYPDNTTDFQRADDKV (22aa)
- RRTAGWNVPIGTLRPFLNWTGPPEPIEAAVARF (33aa)
- RTAGWNVPIGTLRPFLNWTGPPEPIEAAVARF (32aa)
- RVYKPSAGNNSLYRD (15aa)
- VYSSANNCTFE (11aa)
- KREENQEQPRNYSHHQLNRS (20aa)
- CRGLVGSKNVSSE (13aa)
- GSKNVSSE (8aa)
- KGPNCSEPECPGNCHLRG (18aa)
- KEHAVFTSNQEEQDPANHTCGVKS (24aa)
- KMVSHHNLTTGATLINEQWLLTTAKN (26aa)
- KLPPGLLANFTLLRT (15aa)
- RSWPAVGNCSSALRW (15aa)
- TVNITITQGL (10aa)
- TVNITITQGLA (11aa)
- KSIQNVSHLILHMKQ (15aa)
- GLTFQQNASSM(SO)CVPDQDTAIR (25aa)
- GLTFQQNASSMCVPDQDTAIR (21aa)
- RGLTFQQNASSMCVPDQDTAIRV (23aa)
- KNLFLNHSENATAKD (15aa)
- KVVLHPNYSQVDIGLIKL (18aa)
- KLENSLLDHRNKT (13aa)
- KYTGNASALFILPDQDKM (18aa)
- KYLGNATAIFFLPDEGKL (18aa)
- THTNISE (7aa)
- NGTITDAVDCALDPLSE (17aa)
- RHIGHANLTFEQLRS (15aa)
- REIRHNSTGCLRM (13aa)
- RDLGPTLANSTHHNVRL (17aa)
- KNCTSYGVLDISKC (14aa)
- KMFSQNDTRC (10aa)
- KVAYSNDSANWTEYQDPRT (19aa)
- FPNITNLCPFGE (12aa)
- RLAGKPTHVNVSVVMAEVDGTCY (23aa)
- RLAGKPTHVNVSVVMAEVDGTCY- (24aa)
- VFNATR (6aa)
- KKGNTTLNSFVIPSESDVPTHCPSQWWPYAGHCYKI (36aa)
- KVSCPIMPCSNATVPDGECCPRC (23aa)
- RLANLTQGEDQYYLRV (16aa)
- KENLTAPGSDSAVFFEQGTTRI (22aa)
- RLSLLEEPGNGTFTVILNQLTSRD (24aa)
- KVPGNVTAVLGETLKV (16aa)
- RTAGWNIPMGLLFNQTGSCKF (21aa)
- KSCHTAVDRTAGWNIPMGLLFNQTGSCKF (29aa)
- KYWCKWNNTGCQALPSQDEGPSKA (24aa)
- KWNNTGCQALPSQDEGPSKA (20aa)
- KAAIPSALDTNSSKS (15aa)
- KFGRNGSDCPDKF (13aa)
- RNGSDCPDKF (10aa)
- AGCLIGAEHVNNSYE (15aa)
- HVNNSYE (7aa)
- KELHHLQEQNVSNAFLDKG (19aa)
- KVEAARNLTVPGSLRA (16aa)
- RHNLTVPGSLRAS (13aa)
- KTAHCNESFYFLCKR (15aa)
- RGLNVTLSSTGRN (13aa)
- KVEAAQNLTLPGSLRA (16aa)
- RLLETVEYNISGAERT (16aa)
- RTVVCHCNAESQCLYNQTSRV (21aa)
- RDVTALNVSTLKA (13aa)
Mass spectrometry observed peptide
-
- N-Linked / Complex
(avg mass : 2370.1661)
- Blood Plasma (UBERON_0001969)
- Blood Serum (UBERON_0001977) Mature NK T cell (CL_0000814)
- Blood Serum (UBERON_0001977)
- Colostrum (UBERON_0001914)
- Kidney (UBERON_0002113) HEK293 (CVCL_0045)
- Milk (UBERON_0001913)
- Ovary (UBERON_0000992) CHO (CVCL_0213)
- HEK293 (CVCL_0045)
- EBV-transformed B-cell (CL_0000236)
- Neutrophil (CL_0000775)
- Atopic dermatitis (DOID:3310)
- Control/Healthy
- COVID-19 (DOID:0080600)
- Esophageal cancer (DOID:5041)
- Gastritis (DOID:4029)
- Hyper IgE syndrome (DOID:0080545)
- Hyper IgE syndrome (HIES, p.Glu340del) (DOID:0080545)
- Hyper IgE syndrome (PGM3 mutation, p.Asp507Tyr) (DOID:0080545)
- Hyper IgE syndrome (PGM3 mutation, p.Leu83Ser) (DOID:0080545)
- Hyperimmune condition
- IgE myeloma (DOID:9538)
- Multiple myeloma (DOID:9538)
- Systemic lupus erythematosus (DOID:9074)
- Site-specific N-glycosylation Characterization of Recombinant SARS-CoV-2 Spike Proteins using High-Resolution Mass Spectrometry (2020 - Yong Zhang, Wanjun Zhao, Yonghong Mao, Shisheng Wang, Yi Zhong, Tao Su, Meng Gong, Xiaofeng Lu, Jingqiu Cheng, Hao Yang) / Status : Reviewed
- Comprehensive characterization of N- and O- glycosylation of SARS-CoV-2 human receptor angiotensin converting enzyme 2. (2020 - Asif Shajahan, Stephanie Archer-Hartmann, Nitin T. Supekar, Anne S. Gleinich, Christian Heiss, and Parastoo Azadi) / Status : Reviewed
- Cysteine Aminoethylation Enables the Site-Specific Glycosylation Analysis of Recombinant Human Erythropoietin using Trypsin (2020 - Steffen Lippold, Alexander Büttner, Matthew S.F. Choo, Michaela Hook, Coen J. de Jong, Terry Nguyen-Khuong, Markus Haberger, Dietmar Reusch, Manfred Wuhrer, Noortje de Haan) / Status : Reviewed
- Quantitative Longitudinal Inventory of the N-Glycoproteome of Human Milk from a Single Donor Reveals the Highly Variable Repertoire and Dynamic Site-Specific Changes (2020 - Jing Zhu, Yu-Hsien Lin, Kelly A Dingess, Marko Mank, Bernd Stahl, Albert J R Heck) / Status : Reviewed
- Primary Human Natural Killer Cells Retain Proinflammatory IgG1 at the Cell Surface and Express CD16a Glycoforms with Donor-dependent Variability. (2019 - Patel KR, Nott JD, Barb AW) / Status : Unreviewed
- A Microarray-Matrix-assisted Laser Desorption/Ionization-Mass Spectrometry Approach for Site-specific Protein N-glycosylation Analysis, as Demonstrated for Human Serum Immunoglobulin M (IgM) (2015 - Martin Pabst, Simon Karl Küster, Fabian Wahl, Jasmin Krismer, Petra S.Dittrich, Renato Zenobi) / Status : Reviewed
- A Method for Comprehensive Glycosite-Mapping and Direct Quantitation of Serum Glycoproteins (2015 - Qiuting Hong, L. Renee Ruhaak, Carol Stroble, Evan Parker, Jincui Huang, Emanual Maverakis, Carlito B. Lebrilla) / Status : Reviewed
- The serum immunoglobulin G glycosylation signature of gastric cancer (2015 - L. Renee Ruhaak, Donald A. Barkauskas, Javier Torres, Cara L. Cooke, Lauren D. Wu, Carol Stroble, Sureyya Ozcan, Cynthia C. Williams, Margarita Camorlinga, David M. Rocke, Carlito B. Lebrilla, Jay V. Solnick,) / Status : Reviewed
- Expression and glycoengineering of functionally active heteromultimeric IgM in plants (2014 - Loos A, Gruber C, Altmann F, Mehofer U, Hensel F, Grandits M, Oostenbrink C, Stadlmayr G, Furtmüller PG, Steinkellner H) / Status : Reviewed
- In-depth analysis of site-specific N-glycosylation in vitronectin from human plasma by tandem mass spectrometry with immunoprecipitation (2014 - Hwang H, Lee JY, Lee HK, Park GW, Jeong HK, Moon MH, Kim JY, Yoo JS.) / Status : Reviewed
- Site-specific N-glycosylation analysis of human immunoglobulin E. (2014 - Plomp R, Hensbergen PJ, Rombouts Y, Zauner G, Dragan I, Koeleman CA, Deelder AM, Wuhrer M) / Status : Reviewed
- Site-specific glycan microheterogeneity of inter-alpha-trypsin inhibitor heavy chain H4 (2014 - Chandler KB, Brnakova Z, Sanda M, Wang S, Stalnaker SH, Bridger R, Zhao P, Wells L, Edwards NJ, Goldman R.) / Status : Reviewed
- Hypomorphic homozygous mutations in phosphoglucomutase 3 (PGM3) impair immunity and increase serum IgE levels, (2014 - Atfa Sassi, Sandra Lazaroski, Gang Wu, Stuart M. Haslam, Manfred Fliegauf, Fethi Mellouli, Turkan Patiroglu, Ekrem Unal, Mehmet Akif Ozdemir, Zineb Jouhadi, Khadija Khadir, Leila Ben-Khemis, Meriem Ben-Ali, Imen Ben-Mustapha, Lamia Borchani, Dietmar Pfeifer, Thilo Jakob, Monia Khemiri, A. Charlotta Asplund, Manuela O. Gustafsson, Karin E. Lundin, Elin Falk-Sörqvist, Lotte N. Moens, Hatice Eke Gungor, Karin R. Engelhardt, Magdalena Dziadzio, Hans Stauss, Bernhard Fleckenstein, Rebecca Meier, Khairunnadiya Prayitno, Andrea Maul-Pavicic, Sandra Schaffer, Mirzokhid Rakhmanov, Philipp Henneke, Helene Kraus, Hermann Eibel, Uwe Kölsch, Sellama Nadifi, Mats Nilsson, Mohamed Bejaoui, Alejandro A. Schäffer, C.I. Edvard Smith, Anne Dell, Mohamed-Ridha Barbouche, Bodo Grimbacher) / Status : Reviewed
- Site-specific N-glycosylation analysis of human factor XI: Identification of a noncanonical NXC glycosite (2014 - Faid V, Denguir N, Chapuis V, Bihoreau N, Chevreux G) / Status : Reviewed
- Computational framework for identification of intact glycopeptides in complex samples (2014 - Mayampurath A, Yu CY, Song E, Balan J, Mechref Y, Tang H.) / Status : Reviewed
- Loci Associated with N-Glycosylation of Human Immunoglobulin G Show Pleiotropy with Autoimmune Diseases and Haematological Cancers (2013 - Gordan Lauc, Jennifer E. Huffman, Maja Pučić, Lina Zgaga, Barbara Adamczyk, Ana Mužinić, Mislav Novokmet, Ozren Polašek, Olga Gornik, Jasminka Krištić, Toma Keser, Veronique Vitart, Blanca Scheijen, Hae-Won Uh, Mariam Molokhia, Alan Leslie Patrick, Paul McKeigue,Ivana Kolčić, Ivan Krešimir Lukić, Olivia Swann, Frank N. van Leeuwen, L. Renee Ruhaak, Jeanine J. Houwing-Duistermaat, P. Eline Slagboom, Marian Beekman, Anton J. M. de Craen, André M. Deelder, Qiang Zeng, Wei Wang, Nicholas D. Hastie, Ulf Gyllensten, James F. Wilson, Manfred Wuhrer, Alan F. Wright, Pauline M. Rudd, Caroline Hayward, Yurii Aulchenko, Harry Campbell, Igor Rudan) / Status : Reviewed
- Exploring site-specific N-glycosylation microheterogeneity of haptoglobin using glycopeptide CID tandem mass spectra and glycan database search (2013 - Chandler KB1, Pompach P, Goldman R, Edwards N.) / Status : Reviewed
- GlycoSpectrumScan: Fishing Glycopeptides from MS Spectra of Protease Digests of Human Colostrum sIgA (2010 - Nandan Deshpande, Pia H. Jensen, Nicolle H. Packer, Daniel Kolarich) / Status : Reviewed
- Differential Glycosylation of Polymeric and Monomeric IgA: A Possible Role in Glomerular Inflammation in IgA Nephropathy (2006 - Beatrijs D. Oortwijn, Anja Roos, Louise Royle, Daniëlle J. van Gijlswijk-Janssen, Maria C. Faber-Krol, Jan-Willem Eijgenraam, Raymond A. Dwek, Mohamed R. Daha, Pauline M. Rudd, Cees van Kooten) / Status : Reviewed
- Human Serum IgM Glycosylation: IDENTIFICATION OF GLYCOFORMS THAT CAN BIND TO MANNAN-BINDING LECTIN (2005 - James N.Arnold, Mark R.Wormald, David M.Suter, Catherine M.Radcliffe, David J.Harvey, Raymond A.Dwek, Pauline M.Rudd, Robert B.Sim) / Status : Reviewed
- ADAM DEC1 / Homo sapiens
- Alpha-1-antichymotrypsin / Homo sapiens
- Alpha-1-antitrypsin / Homo sapiens
- Alpha-S1-casein / Homo sapiens
-
Angiotensin-converting enzyme 2 / Homo sapiens
- Undefined site
- Apolipoprotein D / Homo sapiens
- Beta-2-glycoprotein 1 / Homo sapiens
- Butyrophilin subfamily 1 member A1 / Homo sapiens
- Carbonic anhydrase 6 / Homo sapiens
- Ceruloplasmin / Homo sapiens
- Chordin-like protein 2 / Homo sapiens
- Clusterin / Homo sapiens
- Coagulation factor XI / Homo sapiens
- Complement c4-a / Homo sapiens
- Complement C4-B / Homo sapiens
- Erythropoietin / Homo sapiens
- Galectin-3-binding protein / Homo sapiens
- Glucosylceramidase / Homo sapiens
- Haptoglobin / Homo sapiens
- Hemopexin / Homo sapiens
-
Immunoglobulin alpha (non secretory) / Homo sapiens
- Undefined site
- Immunoglobulin epsilon chain c region / Homo sapiens
-
Immunoglobulin gamma / Homo sapiens
- Undefined site
- Immunoglobulin heavy constant alpha 1 / Homo sapiens
- Immunoglobulin heavy constant alpha 2 / Homo sapiens
- Immunoglobulin heavy constant mu / Homo sapiens
- Immunoglobulin J chain / Homo sapiens
- Inter-alpha-trypsin inhibitor heavy chain h4 / Homo sapiens
- Lactadherin / Homo sapiens
- Lactotransferrin / Homo sapiens
- Leucine-rich alpha-2-glycoprotein / Homo sapiens
- Lipoprotein lipase / Homo sapiens
- Low affinity immunoglobulin gamma Fc region receptor III-A (FcγRIIIa ) / Homo sapiens
- Lumican / Homo sapiens
- Macrophage mannose receptor 1 / Homo sapiens
- Metalloproteinase inhibitor 1 / Homo sapiens
- Platelet glycoprotein 4 / Homo sapiens
- Polymeric immunoglobulin receptor / Homo sapiens
- Prosaposin / Homo sapiens
- Recombinant Mucin-1 Muc1f/4tr / Homo sapiens
- Selenoprotein P / Homo sapiens
- Sparc-like protein 1 / Homo sapiens
- Sulfhydryl oxidase 1 / Homo sapiens
- Tenascin / Homo sapiens
- Thrombospondin-1 / Homo sapiens
- Toll-like receptor 2 / Homo sapiens
- Trans-Golgi network integral membrane protein 2 / Homo sapiens
- Tumor necrosis factor ligand superfamily member 13 / Homo sapiens
- Tumor necrosis factor receptor superfamily member 11B / Homo sapiens
- Vitronectin / Homo sapiens
- Zinc-alpha-2-glycoprotein / Homo sapiens
- Recombinant Spike glycoprotein (HEK293) / Severe acute respiratory syndrome coronavirus 2 (2019-nCoV)
- KQEEAGVRPSAGNVSTHPSLSQRPGGSTKS (30aa)
- YKNNSDISSTR (11aa)
- NNSDISSTR (9aa)
- EAENITTGC (9aa)
- KFVGTPEVNQTTLYQRY (17aa)
- RLSPNASAEHLELRW (15aa)
- FHNESLISSQASSY (14aa)
- KGLNMTGYETQAGEFPMVNNGHTVQISLPSTMRM (34aa)
- RNESTQNCVVAEPEKM (16aa)
- RALGFENATQALGRA (15aa)
- KDTRNESTQNCVVAEPEKM (19aa)
- RTPEDTAEDTCHLIPGVAESVATCHFNHSSKT (32aa)
- ENISDPTSPLR (11aa)
- IIVPLNNRENISDPTSPLR (19aa)
- RIIVPLNNRENISDPTSPLRT (21aa)
- RENISDPTSPLRT (13aa)
- RANLTNFPENGTFVVNIAQLSQDDSGRY (28aa)
- KNNATVHEQVGGPSLTSDLQAQSKG (25aa)
- KKKEDALNETRE (12aa)
- KKKEDALNETRESETKL (17aa)
- KEDALNETRESETKL (15aa)
- KKEDALNETRESETKL (16aa)
- KKEDALNETRE (11aa)
- RADGTVNQIEGEATPVNLTEPAKL (24aa)
- KTCDWLPKPNMSASCKE (17aa)
- RSHNRSEEFLIAGKL (15aa)
- KNDTLLGIKG (10aa)
- KFNLTETSEAEIHQSFQHLLRT (22aa)
- KDIVEYYNDSNGSHVLQGRF (20aa)
- KSCQHNGTMYQHGEIFSAHELFPSRL (26aa)
- KVSEHIPVYQQEENQTDVWTLLNGSKD (27aa)
- TQSLLIVNNATNVVIK (16aa)
- KQHSVLHLVPINATSKD (17aa)
- KKLHINHNNLTESVGPLPKS (20aa)
- KLHINHNNLTESVGPLPKS (19aa)
- KNGSGAVFPVAGADVQTLRE (20aa)
- RGLSFDVSLEVSQGPGLLNDTKV (23aa)
- KEHEGAIYPDNTTDFQRA (18aa)
- KEHEGAIYPDNTTDFQRADDKV (22aa)
- RRTAGWNVPIGTLRPFLNWTGPPEPIEAAVARF (33aa)
- RTAGWNVPIGTLRPFLNWTGPPEPIEAAVARF (32aa)
- RVYKPSAGNNSLYRD (15aa)
- VYSSANNCTFE (11aa)
- KREENQEQPRNYSHHQLNRS (20aa)
- CRGLVGSKNVSSE (13aa)
- GSKNVSSE (8aa)
- KGPNCSEPECPGNCHLRG (18aa)
- KEHAVFTSNQEEQDPANHTCGVKS (24aa)
- KMVSHHNLTTGATLINEQWLLTTAKN (26aa)
- KLPPGLLANFTLLRT (15aa)
- RSWPAVGNCSSALRW (15aa)
- TVNITITQGL (10aa)
- TVNITITQGLA (11aa)
- KSIQNVSHLILHMKQ (15aa)
- GLTFQQNASSM(SO)CVPDQDTAIR (25aa)
- GLTFQQNASSMCVPDQDTAIR (21aa)
- RGLTFQQNASSMCVPDQDTAIRV (23aa)
- KNLFLNHSENATAKD (15aa)
- KVVLHPNYSQVDIGLIKL (18aa)
- KLENSLLDHRNKT (13aa)
- KYTGNASALFILPDQDKM (18aa)
- KYLGNATAIFFLPDEGKL (18aa)
- THTNISE (7aa)
- NGTITDAVDCALDPLSE (17aa)
- RHIGHANLTFEQLRS (15aa)
- REIRHNSTGCLRM (13aa)
- RDLGPTLANSTHHNVRL (17aa)
- KNCTSYGVLDISKC (14aa)
- KMFSQNDTRC (10aa)
- KVAYSNDSANWTEYQDPRT (19aa)
- FPNITNLCPFGE (12aa)
- RLAGKPTHVNVSVVMAEVDGTCY (23aa)
- RLAGKPTHVNVSVVMAEVDGTCY- (24aa)
- VFNATR (6aa)
- KKGNTTLNSFVIPSESDVPTHCPSQWWPYAGHCYKI (36aa)
- KVSCPIMPCSNATVPDGECCPRC (23aa)
- RLANLTQGEDQYYLRV (16aa)
- KENLTAPGSDSAVFFEQGTTRI (22aa)
- RLSLLEEPGNGTFTVILNQLTSRD (24aa)
- KVPGNVTAVLGETLKV (16aa)
- RTAGWNIPMGLLFNQTGSCKF (21aa)
- KSCHTAVDRTAGWNIPMGLLFNQTGSCKF (29aa)
- KYWCKWNNTGCQALPSQDEGPSKA (24aa)
- KWNNTGCQALPSQDEGPSKA (20aa)
- KAAIPSALDTNSSKS (15aa)
- KFGRNGSDCPDKF (13aa)
- RNGSDCPDKF (10aa)
- AGCLIGAEHVNNSYE (15aa)
- HVNNSYE (7aa)
- KELHHLQEQNVSNAFLDKG (19aa)
- KVEAARNLTVPGSLRA (16aa)
- RHNLTVPGSLRAS (13aa)
- KTAHCNESFYFLCKR (15aa)
- RGLNVTLSSTGRN (13aa)
- KVEAAQNLTLPGSLRA (16aa)
- RLLETVEYNISGAERT (16aa)
- RTVVCHCNAESQCLYNQTSRV (21aa)
- RDVTALNVSTLKA (13aa)
Source
Disease
Reference
Reported glycosite
Mass spectrometry observed peptide
3D structure from GLYCAM
- N-Linked / Complex
(avg mass : 2370.1661)